SuperDendrix also identifies increased dependencies on PIK3CA and BCL2 in some of the same cancer types, including PIK3CA in myeloma and rhabdomyosarcoma and BCL2 in leukemia and myeloma.100. This evidence concerns the gene PIK3CA and plasma cell myeloma.